Nasr 2013.
| Methods | Parallel randomised controlled trial in university‐affiliated tertiary centre, Egypt Timing: Not stated |
|
| Participants | 80 women randomised Mean age of unilateral drilling group was 28.4 ± 2.2 years and in bilateral group was 29.2 ± 1.9 years Inclusion criteria: Clomiphene‐resistant PCOS Exclusion criteria: No details |
|
| Interventions | Unilateral drilling (n = 40), versus Bilateral drilling (n = 40) 40 normally‐ovulating women were included as controls but not included in this review and were not randomised Follow‐up for 6 months |
|
| Outcomes | Serum anti‐Mullerian hormone at 6 months follow‐up | |
| Notes | Conflict of interest: not stated Clinical trial registration number: not stated Conference abstract only |
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | Quote: "randomized" Comment: no other details |
| Allocation concealment (selection bias) | Unclear risk | No details |
| Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | No details |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No details |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | 80 women randomised but not clear if all women were analysed at 6 months |
| Selective reporting (reporting bias) | High risk | Conference abstract that only reported on anti‐Mullerian hormone, which was not a prespecified outcome for this review |
| Other bias | High risk | States that groups were balanced at baseline but conference abstract only. No tables or P values identified |